Response to Modabber and Harissi-Dagher’s Letter: “Type 1 Boston Keratoprosthesis for Limbal Stem Cell Deficiency in Epidermolysis Bullosa”

N. Geetha SravaniOphthalmic Biophysics, L V Prasad Eye Institute, Hyderabad, India

http://orcid.org/0000-0002-3362-9222

, BS Opt

Ashik MohamedOphthalmic Biophysics, L V Prasad Eye Institute, Hyderabad, India

http://orcid.org/0000-0001-5520-4930

, MBBS, MTech, PhD

Virender S. SangwanTej Kohli Cornea Institute, L V Prasad Eye Institute, Hyderabad, India;Centre for Ocular Regeneration, L V Prasad Eye Institute, Hyderabad, IndiaCorrespondence[email protected]

http://orcid.org/0000-0002-8229-4158

, MBBS, MS

References

Sravani NG, Mohamed A, Sangwan VS. Type 1 Boston keratoprosthesis for limbal stem cell deficiency in Epidermolysis Bullosa. Ocul Immunol Inflamm. 2017;1–3. doi:10.1080/09273948.2017.1390588.
PubMedGoogle Scholar
Fung SSM, Jabbour S, Harissi-Dagher M, et al. Visual outcomes and complications of Type I Boston keratoprosthesis in children: a retrospective multicenter study and literature review. Ophthalmology. 2018;125:153–160.
PubMed Web of Science ®Google Scholar
Trief D, Marquezan MC, Rapuano CJ, Prescott CR. Pediatric corneal transplants. Curr Opin Ophthalmol. 2017;28:477–484.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Response to Modabber and Harissi-Dagher’s Letter: “Type 1 Boston Keratoprosthesis for Limbal Stem Cell Deficiency in Epidermolysis Bullosa”

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Response to Modabber and Harissi-Dagher’s Letter: “Type 1 Boston Keratoprosthesis for Limbal Stem Cell Deficiency in Epidermolysis Bullosa”

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date